AUSTIN, TEXAS — CBD producer Socati Corp., a subsidiary of Yooma Wellness Inc., is launching Socati Formulations, a new CBD formulation and product development division.
Socati Formulations will provide a full concept-to-market service for brands building products that feature customized cannabinoid ratios while also incorporating trending functional ingredients like elderberry, ashwagandha, curcumin, melatonin, L-Theanine and Rhodiola rosea, among others.
The new division was inspired by the increased global focus on wellness brought on by the pandemic, according to the company. It was launched in response to a growing demand in the CBD market for good manufacturing practice (GMP)-quality finished products with certified organic cannabinoids and a variety of other functional ingredients recognized for overall wellness benefits.
“We’re seeing new and exciting trends in the CBD space, which we’re fortunate to be able to react to quickly and with world-class expertise,” said Mark Elfenbein, chief revenue officer at Socati. “With a sharp focus on well-being seen around the world, an increasing number of people are looking for new and innovative products with ingredients they know and trust.”
The company established a team of formulation and product development experts within its new division. Building on Socati’s finished goods catalogue and the launch of dozens of products, ranging from gummies and tinctures to its proprietary water-dispersible flavored crystal stick packs, the team will provide a turnkey service for new and existing customers looking to bring fresh and innovative products to market.
“Yooma is extremely excited about the launch of Socati Formulations,” said Lorne Abony, chairman of Yooma. “The Socati team is already working with several leading consumer brands to create new and unique products that will be available to customers in the coming weeks and months.”